HD-OPM Archive
Topics › Aging & longevity

Systematic review: repurposing cardiometabolic drugs to extend lifespan in animals

Gokhan Can · Jul 11, 2024 · ♥ 16 reactions · 14 comments · original Facebook post
Aging & longevityCardiovascular disease: the big picture
AI summary & key facts

Gokhan shares a Frontiers in Pharmacology systematic review on cardiometabolic drugs repurposed for aging in animal studies and clinical trials. He takes several of these drugs, citing mTOR inhibition and lower glucose, lipid spikes, triglycerides and inflammation.

Paper · Front. Pharmacol. · 2024Repurposing effect of cardiovascular-metabolic drug to increase lifespan: a systematic review of animal studies and current clinical trial progressWith the increase in life expectancy, aging has emerged as a significant health concern. Due to its various mechanisms of action, cardiometabolic drugs are often repurposed for other indications, including aging. This systematic review analyzed and highlighted the repositioning potential of cardiometabolic drugs to increase lifespan as an aging parameter in animal studies and supplemented by information from current…frontiersin.org

(I'm personally on several of these drugs for cardiovascular health and longevity purposes. The benefits go beyond cardiovascular health through various systemic effects such as mtor inhibition, blunting blood glucose and lipid spikes, reducing trigs and inflammation).

Research cited

#cardiovascular#cardiovascularhealth#longevity#mtor#glucose#inflammation
← newer: Ezetimibe linked to over 7-fold lower Alzheimer's and relateolder: Fatigue was an early sign: a marathon runner's heart attack →